Cutaneous T Cell Lymphoma
Oncology
2
Pipeline Programs
3
Companies
3
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
TakedaTOKYO, Japan
1 programSystemic Therapies in the Treatment of Cutaneous T-cell LymphomaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
SoligenixHypericin
PharmaEssentiaRopeginterferon alfa-2b
TakedaSystemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
Clinical Trials (3)
Total enrollment: 410 patients across 3 trials
Treatment of Mycosis Fungoides With Hypericin Ointment and Visible Light
Start: Aug 2023Est. completion: Dec 202510 patients
Phase 2Completed
Ropeginterferon in Patients w/Cutaneous T-Cell Lymphoma (CTCL)
Start: Aug 2025Est. completion: Jun 2028
Phase 1Recruiting
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
Start: Feb 2025Est. completion: Jul 2026400 patients
N/ARecruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
1h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
1h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
1h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 410 patients
3 companies competing in this space